» Articles » PMID: 39566372

Characterizing Heterogeneity in Amyloid Formation Processes

Overview
Date 2024 Nov 20
PMID 39566372
Authors
Affiliations
Soon will be listed here.
Abstract

Protein aggregation is a complex process, consisting of a large number of pathways connecting monomers and mature amyloid fibrils. Recent advances in structure determination techniques, such as solid-state NMR and cryoEM, have allowed the determination of atomic resolution structures of fibril polymorphs, but most of the intermediate stages of the process including oligomer formation remain unknown. Proper characterization of the heterogeneity of the process is critical not only for physical and chemical understanding of the aggregation process but also for elucidation of the disease mechanisms and identification of therapeutic targets. This article reviews recent developments in the characterization of heterogeneity in amyloid formation processes.

References
1.
Kotler S, Tugarinov V, Schmidt T, Ceccon A, Libich D, Ghirlando R . Probing initial transient oligomerization events facilitating Huntingtin fibril nucleation at atomic resolution by relaxation-based NMR. Proc Natl Acad Sci U S A. 2019; 116(9):3562-3571. PMC: 6397591. DOI: 10.1073/pnas.1821216116. View

2.
Chiti F, Dobson C . Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade. Annu Rev Biochem. 2017; 86:27-68. DOI: 10.1146/annurev-biochem-061516-045115. View

3.
Meng F, Kim J, Louis J, Chung H . Single-Molecule Characterization of Heterogeneous Oligomer Formation during Co-Aggregation of 40- and 42-Residue Amyloid-β. J Am Chem Soc. 2024; 146(35):24426-24439. DOI: 10.1021/jacs.4c06372. View

4.
Mucibabic M, Apetri M, Canters G, Aartsma T . The effect of fluorescent labeling on α-synuclein fibril morphology. Biochim Biophys Acta. 2016; 1864(10):1419-27. DOI: 10.1016/j.bbapap.2016.07.007. View

5.
Lovestam S, Koh F, van Knippenberg B, Kotecha A, Murzin A, Goedert M . Assembly of recombinant tau into filaments identical to those of Alzheimer's disease and chronic traumatic encephalopathy. Elife. 2022; 11. PMC: 8983045. DOI: 10.7554/eLife.76494. View